FORBES
RS Research was listed in among the most successful startups in Forbes’ 2025 Startup 50!
About RS Research
This author has not written his bio yet.
But we are proud to say that RS Research contributed 66 entries already.
Entries by RS Research
FAST COMPANY
RS Research was listed 13th in Fast Company’s 50 Most Innovative Companies 2024
Prof. Rana Sanyal won the European Prize for Women Innovators
“Women Innovators” Prize in the leading category of the European Prize for Women Innovators program was awarded to RS Research Co-Founder Prof. Rana Sanyal for her successful work in the field of biotechnology. […]
DÜNYA
RS Research has been selected to join the inaugural cohort of prestigious Turcorn100 Program
PARA
Para: 60 Amazing Women: Women in Science in Türkiye
RS Research announces poster presentation at the ESMO TAT 2023 Congress
RS Research, a clinical-stage biotechnology start-up developing smart nanomedicines for targeted chemotherapy, announced the acceptance of a poster presentation at the European Society for Medical Oncology Targeted Anticancer Therapies (ESMO TAT) 2023 Congress on 6-8 March in Paris – France, being known as “The Home of Phase I in Oncology”. […]
HURRIYET DAILY NEWS
Turkish company RS Research received the Entrepreneur of the Year Award
EKONOMIST
Female Stars of the Start-up World
RS Research announces poster presentation at the ESMO 2022 Congress about RS-0139’s ongoing clinical trial on NSCLC
RS Research, a clinical-stage biotechnology start-up developing smart nanomedicines for targeted chemotherapy, announced the acceptance of a poster presentation at the European Society for Medical Oncology (ESMO) 2022 Congress to be held in person on 9-13 September […]
RS Research is a clinically-validated biotech company developing targeted oncology therapies using Sagitta® drug-delivery platforms, disrupting the efficacy-toxicity trade-off.
